101
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Newly discovered innate response activator B cells: crucial responders against microbial sepsis

&
Pages 405-407 | Published online: 10 Jan 2014

References

  • Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8(10), 776–787 (2008).
  • Boomer JS, To K, Chang KC et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23), 2594–2605 (2011).
  • Rauch PJ, Chudnovskiy A, Robbins CS et al. Innate response activator B cells protect against microbial sepsis. Science 335(6068), 597–601 (2012).
  • Basu S, Dunn AR, Marino MW et al. Increased tolerance to endotoxin by granulocyte–macrophage colony-stimulating factor-deficient mice. J. Immunol. 159(3), 1412–1417 (1997).
  • Spight D, Trapnell B, Zhao B, Berclaz P, Shanley TP. Granulocyte–macrophage colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock 30(4), 434–442 (2008).
  • Gennari R, Alexander JW, Gianotti L, Eaves-Pyles T, Hartmann S. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance. Ann. Surg. 220(1), 68–76 (1994).
  • Carr R, Brocklehurst P, Doré CJ, Modi N. Granulocyte–macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 373(9659), 226–233 (2009).
  • Bo L, Wang F, Zhu J, Li J, Deng X. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit. Care 15(1), R58 (2011).
  • Metcalf D, Nicola NA, Mifsud S, Di Rago L. Receptor clearance obscures the magnitude of granulocyte–macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood 93(5), 1579–1585 (1999).
  • Fleischmann J, Golde DW, Weisbart RH, Gasson JC. Granulocyte–macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68(3), 708–711 (1986).
  • Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188(12), 2381–2386 (1998).
  • Ghosh K, Kanapathipillai M, Korin N, McCarthy JR, Ingber DE. Polymeric nanomaterials for islet targeting and immunotherapeutic delivery. Nano Lett. 12(1), 203–208 (2012).
  • Neves P, Lampropoulou V, Calderon-Gomez E et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33(5), 777–790 (2010).
  • Kelly-Scumpia KM, Scumpia PO, Weinstein JS et al. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208(8), 1673–1682 (2011).
  • Fritz JH, Rojas OL, Simard N et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481(7380), 199–203 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.